Once-daily intravenous busulfan with therapeutic drug monitoring compared to conventional oral busulfan improves survival and engraftment in children undergoing allogeneic stem cell transplantation

I.H. Bartelink, R.G. Bredius, F.F.T. Ververs, M.F. Raphael, Charlotte van Kesteren, M.B. Bierings, C.M.A. Rademaker, J. den Hartigh, C.S.P.M. Uiterwaal, J. Zwaveling, J.J. Boelens

Research output: Contribution to journal › Article › Academic › peer-review

Fingerprint

Dive into the research topics of 'Once-daily intravenous busulfan with therapeutic drug monitoring compared to conventional oral busulfan improves survival and engraftment in children undergoing allogeneic stem cell transplantation'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science